Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,036 | -116,658 | -110,218 | -92,287 | -50,463 |
| Depreciation Amortization | 4,261 | 4,291 | 1,253 | 50 | 27 |
| Accounts receivable | -3,683 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 927 | -3,490 | -1,045 | 3,526 | 1,528 |
| Other Working Capital | 5,775 | -35 | -2 | 5,781 | -2,366 |
| Other Operating Activity | 61,831 | 13,889 | 11,959 | 7,373 | 2,708 |
| Operating Cash Flow | $-60,925 | $-102,003 | $-98,053 | $-75,557 | $-48,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -6,896 | -48,147 | -35,307 | -8,564 |
| Net Acquisitions | N/A | -22,174 | N/A | N/A | N/A |
| Investing Cash Flow | $-120 | $-29,070 | $-48,147 | $-35,307 | $-8,564 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8,942 | N/A | N/A | N/A |
| Common Stock Issued | 140,222 | 41,540 | 94,503 | 212,487 | 118,503 |
| Common Stock Repurchased | N/A | -13,965 | N/A | N/A | N/A |
| Other Financing Activity | -5,350 | 0 | -6,659 | 0 | 4,602 |
| Financing Cash Flow | $134,872 | $36,517 | $87,844 | $212,487 | $123,105 |
| Exchange Rate Effect | 4 | -65 | -74 | -31 | -16 |
| Beginning Cash Position | 25,849 | 120,470 | 178,900 | 77,308 | 11,349 |
| End Cash Position | 99,680 | 25,849 | 120,470 | 178,900 | 77,308 |
| Net Cash Flow | $73,831 | $-94,621 | $-58,430 | $101,592 | $65,959 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,925 | -102,003 | -98,053 | -75,557 | -48,566 |
| Capital Expenditure | -120 | -7,895 | -48,147 | -35,307 | -8,564 |
| Free Cash Flow | -61,045 | -109,898 | -146,200 | -110,864 | -57,130 |